DMRA 8-K 2026-07-20

Damora Therapeutics, Inc. (DMRA) 8-K dated 2026-07-20 — accession 0001193125-26-308899.

Damora Therapeutics, Inc. (DMRA) common stock.

Damora Therapeutics, Inc. filed a 8-K on 2026-07-20. Accession 0001193125-26-308899.

This 8-K covers: Material agreement (Item 1.01), Change to holders' rights (Item 3.03), Bylaws or fiscal year change (Item 5.03), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Income-statement cache for DMRA is thin on this filing URL. We will not invent exhibit numbers.

Not investment advice. The DMRA SEC hub lists recent forms. The stock page is the research view.